mind body glp 1 activator Dual-action obesity drug rewires brain circuits for appetite Nutritional priorities to support GLP-1

AstraZeneca, Novo Nordisk A/S, Eli Lilly and Company, Sanofi and Hypera S.A

New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- Zealthy today announced an expansion of its insurance-coordination program for eligible patients...

Novo Nordisk, EVOKE and EVOKE+ phase 3 trial topline results, Alzheimers Association statement, 2025

Take a deep dive into Eli Lilly's latest clinical GLP-1 results that sent shares soaring

Ulcerative colitis is one such novel research target for GLP-1 analogs

An increasing number of patients treated with novel antidiabetic drugs, including glucagon-like-peptide-1 receptor agonists (GLP-1RA), dual glucose-dependent insulinotropic polypeptide receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are presenting in the perioperative...